Eli Lilly registers Phase 3 study of EloraTZP in obesity
The study, NCT07881432 (AMPLIFY-1), was first posted on ClinicalTrials.gov on October 19, 2026. It plans to enroll 2115 participants, start in December 2026, and reach primary completion in October 2029.
Primary source
ClinicalTrials.gov registry record, October 19, 2026
A Study of EloraTZP in Adult Participants With Obesity Without Type 2 Diabetes
Read the source: A Study of EloraTZP in Adult Participants With Obesity Without Type 2 Diabetes clinicaltrials.gov
Machine-summarized from the source above; not independently reported. How we use automation